⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5163608 | 0.72 | — | — | |
| SCHEMBL314943 | 0.72 | — | — | |
| SCHEMBL7066472 | 0.72 | — | — | |
| SCHEMBL8961021 | 0.72 | — | — | |
| SCHEMBL9427 | 0.72 | — | — | |
| SCHEMBL295143 | 0.72 | — | — | |
| SCHEMBL23451722 | 0.67 | — | — | |
| SCHEMBL6014696 | 0.67 | — | — | |
| SCHEMBL3287802 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL7173417 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030054980-A1 | Ceruloplasmin and uses thereof in neurodegenerative related conditions | UNIVERSITE DU QUEBEC A MONTREAL (CA) | 2003-03-20 | — | — | US | disclosed |
| WO-2001082954-A2 | CERULOPLASMIN AND USES THEREOF IN NEURODEGENERATIVE RELATED CONDITIONS | UNIVERSITE DU QUEBEC A MONTREAL (CA) | 2001-11-08 | — | — | WO | disclosed |
| WO-2000005246-A1 | THIOAZEPINONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIATES THEREFOR, USE AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | HOECHST MARION ROUSSEL (FR) | 2000-02-03 | — | — | WO | disclosed |
| CN-1133840-A | Indolepiperidine derivatives | MERCK PATENT GMBH (DE) | 1996-10-23 | — | — | CN | disclosed |
| EP-0102510-B1 | SUBSTITUTED 4-FLUOROPYRIDAZ-6-ONES | BASF Aktiengesellschaft (DE) | 1987-10-07 | — | — | EP | disclosed |
| EP-0102510-A1 | Substituted 4-fluoropyridaz-6-ones | BASF Aktiengesellschaft (DE) | 1984-03-14 | — | — | EP | disclosed |